原创：危重症患者血清胱抑素C与预后关系的临床研究 - 医学论文发表 - xzbu.com 中国论文网 关键词] 危重病;血清胱抑素C;预后 [gap=1049]Key words] Critical disease;Serum Cys C;Prognosis
基于8个网页-相关网页
Serum Cys C 血清胱抑素C
Adopting serum Cys C,urineβ2-MG as laboratory targets,two groups were observed the improvement of study before and after the treatment,and contrast the appraisal of the clinical curative effect improvement situation between two groups.
采用新颖、灵敏的血清胱抑素C(Cys C)、β2-微球蛋白(β2-MG)作为实验室观测指标,观察治疗前后两组疗效指标的改善情况,并对比评价组间的临床疗效改善情况。
参考来源 - 益气活血化痰法对冠心病患者介入诊疗术后造影剂肾损害影响的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
ResultsThe levels of serum Cys C and hs-CRP in diabetic nephropathy group is higher than normal control group and T2DM without complications group(P<0.05).
结果：2型糖尿病早期肾损害组的胱抑素C与超敏C-反应蛋白的值均高于正常对照组和无并发症的2型糖尿病组，其差异具有统计学意义（P<0.05）。
Conclusion: Serum CYS-C is a high sensitive and specific marker in earlier period diagnosis of children kidney diseases and functional lesion of glomerular filtration.
结论血清cys - C是儿童肾脏疾病及其肾小球滤过功能损害早期诊断高敏感性和特异性指标。
应用推荐